ALBRIOZA Approved as a Treatment for ALS in Canada with Conditions
June 15, 2022
Amylyx Pharmaceuticals, Inc announced that ALBRIOZA approved as a treatment for ALS in Canada with conditions by Health Canada.
Read More >>
ALS Society
of Manitoba
La Société
Manitobaine de la SLA
Research
Category: Research
>
TOP